🇺🇸 FDA
Pipeline program

anti-thymocyte globulin

199/15104

Unknown small_molecule terminated

Quick answer

anti-thymocyte globulin for Immunologic Deficiency Syndromes is a Unknown program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Immunologic Deficiency Syndromes
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials